Grant supports quality improvement in community health centers

August 29, 2013 Categories: Advisories & Comments

For Immediate Release


DALLAS, August 27, 2013 ― A GE Foundation grant to The Guideline Advantage™ will help healthcare providers at 12 Federally Qualified Health Centers (FQHCs) measure and compare the quality of outpatient care for preventing and treating cardiovascular diseases, cancer and diabetes during the next two years.

      The Guideline Advantage is a collaboration of the American Cancer Society, American Diabetes Association and American Heart Association. The program targets four of the 10 leading causes of death ― heart disease, cancer, stroke and diabetes ― which share many similar risk factors. The goal is to improve prevention and treatment of these conditions in patients in outpatient settings including doctors’ offices and health clinics. The program includes more than 120,000 patients being seen in more than 30 participating practices since January 2013.

      The $880,000 GE Foundation grant will fund a pilot program in selected FQHCs to drive population health improvement and disease management. FQHCs are community-based organizations that provide comprehensive primary care and preventive services. More than 1,000 FQHCs serve 20 million people nationwide.

     The GE Foundation provided the grant as part of GE’s Developing Health™ initiative, a $50 million program that aims to help improve access to primary care in targeted underserved communities across the U.S.

     “Patients in these health centers are more likely to be uninsured or underinsured, live in medically underserved areas and may experience more chronic conditions than other patients,” said Bob Corcoran, Vice President of GE Corporate Citizenship. “This program will provide doctors with the ability to more easily gather, access and report on important data that can ultimately lead to improved quality and outcomes for patients.”

     The first health centers selected for 2013 are: Newark Community Health Center in Newark, New Jersey; Albany Primary Health Care in Albany, Georgia; Variety Care in Oklahoma City, Oklahoma and the District of Columbia Primary Care Association’s eight participating locations. Eight additional centers are currently being recruited for participation.

     “We are very pleased that the GE Foundation has provided the opportunity to expand this valuable program into needed areas of the country,” said Mary Ann Bauman, M.D., chairperson of The Guideline Advantage committee. “Our research-based guidelines tell us the assessments we should be making, the questions we should be asking and the screenings we should be recommending. The Guideline Advantage helps providers use these guidelines to ultimately improve the way they care for patients who have or who are at-risk for these conditions.”

      The Guideline Advantage uses the technology of Forward Health Group to collect, analyze and provide feedback on adherence to treatment guidelines. Working with Electronic Health Record (EHR) data from practices across the country, the program helps providers capture information that can be used for quality improvement efforts and for future research in cancer, diabetes, heart disease and stroke.


About The Guideline Advantage

The Guideline Advantage is the latest initiative of the Preventive Health Partnership, a collaboration of the American Cancer Society, American Diabetes Association and American Heart Association to develop and pursue strategies for the prevention and early detection of cancer, cardiovascular disease and diabetes. To learn more, visit

About the GE Foundation

The GE Foundation, the philanthropic organization of GE, works to solve some of the world’s most difficult problems. With its partners, the GE Foundation focuses its efforts in the areas of health, education, the environment and disaster relief. In 2012, the GE family invested more than $200 million to global community and educational needs. For more information, visit


The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association’s science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical companies and device manufacturers, is available at


Michael Burton, (214) 706-1236,
Cathy Lewis, (214) 706-1324,